Where imaging can matter

W. De Backer (Antwerp, Belgium)

Source: International Congress 2014 – AirPROM: can imaging and modelling take us beyond FEV1?
Session: AirPROM: can imaging and modelling take us beyond FEV1?
Session type: Session
Number: 2844

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. De Backer (Antwerp, Belgium). Where imaging can matter. International Congress 2014 – AirPROM: can imaging and modelling take us beyond FEV1?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
3D imaging of London roadside particulate matter
Source: Virtual Congress 2020 – Effects of environmental exposures on lung pathology
Year: 2020


Does histology matter in ILD-CTD?
Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Year: 2020


Small animal imaging using CT, PET and MRI
Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development
Year: 2013


Does it matter who requests HRCT scans?
Source: Annual Congress 2011 - Imaging in oncology and infectious diseases
Year: 2011

MRI
Source: Respipedia Article
Year: 2017

Diagnostic imaging of lung cancer
Source: Eur Respir J 2002; 19: 722-742
Year: 2002



Advances in chest imagery
Source: Annual Congress 2006 - Clinical year in review
Year: 2006


Diagnostic imaging of lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=120
Year: 2001

Imaging of cystic fibrosis: functional MRI versus conventional CT
Source: Annual Congress 2007 - Imaging of inflammatory airway diseases
Year: 2007


Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques
Source: Eur Respir J 2007; 29: 418-422
Year: 2007



Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



The value of magnetic resonance imaging (MRI) with gadolinium as a noninvasive diagnostic method in cardiac sarcoidosis
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008

Radiology of lung cancer
Source: Eur Respir Mon; 2009: 44: 106–135
Year: 2009

Imaging the pleura: CT scan, MRI and PET
Source: ERS Skills Course 2016
Year: 2016

Magnetic resonance imaging (MRI) of the lung as a tool for the non-invasive evaluation of drugs in rat models of airways diseases
Source: Annual Congress 2005 - New modalities and application in lung and airway imaging
Year: 2005


Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001

Advances in imaging
Source: Eur Respir J 2001; 18: 867-871
Year: 2001



Feasibility of spirometry-controlled chest magnetic resonance imaging (MRI) in children
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011


Imaging the inflammatory activity of sarcoidosis
Source: Eur Respir J 2013; 41: 743-751
Year: 2013